Thawing System Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The thawing system market studied was projected to grow with a CAGR of nearly 12.8% over the forecast period. The major factors attributing to the growth of the market are increasing usage of thawing devices in various applications and increasing demand for thawed cells for treatments of different diseases. Furthermore, the growing investments in research and development programs by the biotechnology and pharmaceutical companies are boosting the market growth. The rising number of blood banks and awareness of advantages of plasma therapy are few other factors driving the growth of the market. However, the high cost of automatic devices is the major drawback of market growth.

Key Market Trends

The blood sample segment is projected to dominate the thawing system market

• Since fresh blood and its components can be stored only for a certain period of time, freezing blood products can help enable a steady supply of life-saving transfusions for patients, even in rural areas and other places which are hard to reach. In life sciences research and clinical trials, blood samples are taken from persons taking part in research or trials for evaluations such as measuring metabolites or biomarkers present in the blood of the individual. Generally, relevant blood samples are frozen and stored in a central laboratory for additional retrospective studies and future analysis. Since blood serum is the preferred sample for various clinical assays, many samples are also stored in this way
• The factors pushing the segment growth are the increasing prevalence of hematological diseases and increasing awareness of advantages of plasma therapy. As per the data published by the American Society of Hematology 900,000 people in the United States develop blood clots yearly, and they are accountable for approximately 100,000 casualties each year.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall thawing system market, throughout the forecast period. The market growth is due to the factors such as enhancements in the blood bank and biobank infrastructure, increasing research activities in regenerative medicine as well as cell and gene therapy. Furthermore, growing interest in customized medicine and biomarker discovery, a growing number of biotechnology and pharmaceutical companies, and increasing government funding are the few factors which are driving the market in this region.

Competitive Landscape

The thawing system market is moderately competitive and consists of several major players. Some of the companies which are currently domianting the market are Sartorius AG, BioCision., CytoTherm, Boekel Scientific, Helmer Scientific Inc., Cardinal Health, Barkey GmbH & Co. KG, Helmer Scientific, Sarstedt.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support